Prothena Corporation PLC
SWB:0PT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Prothena Corporation PLC (0PT) under the Base Case is 6.077 EUR per share.
Compared with the current market price of 7.208 EUR, the stock appears
Overvalued by 16% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Prothena Does
Prothena Corporation PLC is a biotechnology company that focuses on diseases caused by harmful proteins, especially neurodegenerative disorders and certain rare amyloid-related conditions. It does not sell a broad line of commercial medicines; instead, it develops drug candidates intended to stop or slow the protein misfolding and buildup that drives these illnesses.
- Headquarters
- Ireland IE
- Employees
- 67
- IPO date
- Dec 21, 2012
Balance Sheet
Continue 0PT Research
Decided on Prothena? Get an email when 0PT reaches the price you’d buy at. Free with an account.
Other Prothena listings
What is the Intrinsic Value of one 0PT stock?
The intrinsic value for
Prothena Corporation PLC (0PT) under the Base Case is 6.077 EUR.
Is 0PT stock undervalued or overvalued?
Compared with the current market price of 7.208 EUR, the stock appears Overvalued by 16% .